Cargando…
Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa
BACKGROUND: Concurrent chemoradiotherapy using weekly cisplatin remains standard of care for locally advanced cervical cancer in Sub-Saharan Africa. While cisplatin remains a popular cancer chemotherapeutic, it has an irreversible ototoxic effect on patients’ auditory system. However, there is a pau...
Autores principales: | Paken, Jessica, Govender, Cyril Devadas, Pillay, Mershen, Feyasa, Merga, Sewram, Vikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072443/ https://www.ncbi.nlm.nih.gov/pubmed/37014872 http://dx.doi.org/10.1371/journal.pone.0283639 |
Ejemplares similares
-
Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa
por: Paken, Jessica, et al.
Publicado: (2021) -
Cisplatin-Associated Ototoxicity: A Review for the Health Professional
por: Paken, Jessica, et al.
Publicado: (2016) -
Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity
por: Paken, Jessica, et al.
Publicado: (2021) -
Perspectives and practices of ototoxicity monitoring
por: Paken, Jessica, et al.
Publicado: (2020) -
Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting
por: Paken, Jessica, et al.
Publicado: (2022)